Lilly's weight-loss drug cuts diabetes risk in overweight patients - Reuters
- Lilly's weight-loss drug cuts diabetes risk in overweight patients Reuters
- Eli Lilly's weight loss drug slashes the risk of developing diabetes in long-term trial CNBC
- Tirzepatide cuts risk of diabetes by 94% in adults with prediabetes and obesity or overweight, drugmaker says CNN
- Lilly weight loss drug prevents diabetes, company says USA TODAY
- Mounjaro/Zepbound Drastically Cuts Risk Of Type 2 Diabetes, Eli Lilly Report Suggests Forbes